Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02463032
Title Efficacy and Safety of GTx-024 in Patients With ER+/AR+ Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors GTX
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Holy Cross Hospital Fort Lauderdale Florida 33308 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
St. Vincent Frontier Cancer Center Billings Montana 59102 United States Details
The West Clinic, PC Memphis Tennessee 38120 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field